Phospho-ATF4 (S245) Antibody

What is Phospho-ATF4 (S245) Antibody and what does it detect?

Phospho-ATF4 (S245) antibody is a research tool that specifically recognizes and binds to ATF4 protein only when phosphorylated at serine 245. ATF4 (Activating Transcription Factor 4) is a key transcription factor involved in the cellular stress response pathway. This antibody allows researchers to detect the phosphorylated form of ATF4, which is crucial for understanding its activation status in various cellular contexts. The antibody is typically generated in rabbits as a polyclonal antibody and recognizes the specific phosphorylation site surrounding S245 of human ATF4 .

The specificity of the antibody is critical - it detects endogenous levels of ATF4 protein only when phosphorylated at Ser245, making it valuable for distinguishing the active, phosphorylated form from the unphosphorylated protein . The antibody's high specificity makes it an essential tool for researchers studying ATF4 activation in cellular stress responses, metabolic pathways, and disease models.

What are the common applications for Phospho-ATF4 (S245) Antibody?

Phospho-ATF4 (S245) antibody is utilized in multiple experimental applications, with the most common being:

• Western Blot (WB): The primary application where the antibody is used to detect phosphorylated ATF4 in cell or tissue lysates. Recommended dilutions typically range from 1:500 to 1:2000 . The observed molecular weight of phospho-ATF4 is approximately 45kDa (actual calculated MW is 39kDa) .

• Immunohistochemistry (IHC): Used to visualize the localization and expression patterns of phosphorylated ATF4 in tissue sections .

• Immunofluorescence/Immunocytochemistry (IF/IC): Allows for subcellular localization studies of phosphorylated ATF4 .

These applications enable researchers to investigate ATF4 phosphorylation in various experimental settings, from in vitro cell culture systems to in vivo tissue analysis. The antibody's versatility makes it valuable for correlating ATF4 phosphorylation status with physiological or pathological conditions, particularly in stress response studies, cancer research, and investigations of metabolic and neurodegenerative disorders.

What is the biological significance of ATF4 phosphorylation at S245?

Phosphorylation of ATF4 at serine 245 (S245) represents a critical regulatory mechanism that significantly impacts its transcriptional activity. This specific phosphorylation event plays several important biological roles:

• Transcriptional Activation: Phosphorylation at S245 by ribosomal protein S6 kinase α-2 (RSK2) enhances ATF4's transcriptional activity, particularly during osteoblast and osteoclast differentiation . This modification directly affects ATF4's ability to regulate target gene expression.

• Stress Response Regulation: As a key transcription factor in the integrated stress response (ISR), phosphorylated ATF4 controls the expression of genes involved in amino acid metabolism, redox balance, and protein folding .

• Cellular Process Modulation: Phospho-ATF4 (S245) impacts cellular processes including apoptosis, autophagy, and metabolism, making it a central regulator in cell fate decisions under stress conditions .

• Disease Relevance: The phosphorylation status of ATF4 at S245 has implications for various pathological conditions, including cancer, neurodegenerative disorders, and metabolic diseases .

Understanding this specific phosphorylation event provides insights into how cells fine-tune their responses to various stressors and how this regulation may be altered in disease states. The phosphorylation represents an important post-translational control mechanism that adds complexity to ATF4's role beyond simple protein expression levels.

How do you optimize Western blot protocols for Phospho-ATF4 (S245) Antibody?

Optimizing Western blot protocols for Phospho-ATF4 (S245) antibody requires careful attention to several critical parameters to ensure specific detection of the phosphorylated form:

• Sample Preparation:

  • Add phosphatase inhibitors (e.g., sodium fluoride, sodium orthovanadate, β-glycerophosphate) to lysis buffers to preserve phosphorylation status

  • Process samples quickly and keep them cold to prevent dephosphorylation

  • Use positive control samples such as HeLa cell lysates, which have been confirmed to express phospho-ATF4

• Antibody Dilution Optimization:

  • Begin with the manufacturer's recommended dilution range (1:500-1:2000)

  • Perform a dilution series to determine optimal signal-to-noise ratio

  • Consider longer incubation times (overnight at 4°C) with more dilute antibody concentrations

• Detection Considerations:

  • The observed molecular weight of phospho-ATF4 is approximately 45kDa, while the calculated MW is 39kDa

  • Enhanced chemiluminescence (ECL) detection systems with increased sensitivity may be required for low abundance phospho-proteins

  • Consider using PVDF membranes instead of nitrocellulose for better protein retention

• Blocking and Washing:

  • Use 5% BSA in TBST rather than milk for blocking as milk contains phosphatases

  • Include 0.05-0.1% Tween-20 in wash buffers to reduce background

  • Multiple thorough washes (at least 3-5 times for 5-10 minutes each) are essential

When troubleshooting, remember that phosphorylation-specific signals may be weaker than total protein signals, and the molecular weight shift from 39kDa to 45kDa is likely due to post-translational modifications that affect protein migration during electrophoresis . Including both phospho-specific and total ATF4 antibodies in parallel blots can provide valuable context for your results.

What controls should be included when using Phospho-ATF4 (S245) Antibody?

Including appropriate controls is critical for validating results with Phospho-ATF4 (S245) antibody. A comprehensive control strategy should include:

• Positive Controls:

  • HeLa cell lysates, which have been confirmed to express phospho-ATF4 (S245)

  • Cells treated with known inducers of the integrated stress response (e.g., thapsigargin, tunicamycin, arsenite)

  • Recombinant phosphorylated ATF4 protein (if available)

• Negative Controls:

  • Samples treated with lambda phosphatase to remove phosphorylation

  • ATF4 knockout or knockdown cell lines

  • Primary antibody omission control to assess secondary antibody specificity

• Specificity Controls:

  • Peptide competition assay using the phospho-peptide immunogen to confirm signal specificity

  • Parallel blots with antibodies against total ATF4 to compare expression patterns

  • Simultaneous detection of known downstream targets to confirm functional activity

• Treatment Validation Controls:

  • Cells treated with kinase inhibitors that block RSK2 (which phosphorylates S245)

  • Time-course experiments showing dynamic phosphorylation changes

  • Samples from different stress conditions to demonstrate context-dependent phosphorylation

• Technical Controls:

  • Loading controls (β-actin, GAPDH) to ensure equal protein loading

  • Molecular weight markers to confirm the observed 45kDa band

  • Secondary antibody-only controls to assess non-specific binding

Including these controls not only validates the specificity of the observed signal but also provides context for interpreting the biological significance of ATF4 phosphorylation at S245 under your experimental conditions.

How does phosphorylation at S245 affect ATF4 stability and transcriptional activity?

Phosphorylation at S245 plays a multifaceted role in regulating both ATF4 stability and its transcriptional activity, functioning as a key regulatory switch in the stress response pathway:

Effects on Transcriptional Activity:

• Enhanced Transcriptional Function: Phosphorylation of ATF4 at S245 by ribosomal protein S6 kinase α-2 (RSK2) significantly upregulates its transcriptional activity, particularly during osteoblast and osteoclast differentiation .

• Target Gene Specificity: This modification may alter ATF4's affinity for specific promoter regions or its interaction with transcriptional co-factors, potentially redirecting its regulatory activity toward certain gene subsets.

• Functional Synergy: S245 phosphorylation works in concert with other post-translational modifications, as shown in the comprehensive modification table:

Impact on Protein Stability:

• Indirect Stabilization: While S245 phosphorylation primarily enhances transcriptional activity, it may indirectly affect stability by altering protein conformation or interaction with degradation machinery.

• Relationship with Degradation Pathway: S245 is distinct from the critical residues directly involved in degradation (S219, S224 within the DSGICMS motif that mediates interaction with β-TrCP) .

• Compensatory Mechanisms: The enhanced transcriptional activity from S245 phosphorylation may compensate for ATF4's intrinsically short half-life (<1 hour under normal conditions) .

The complex interplay between different phosphorylation sites on ATF4 creates a sophisticated regulatory network. While S219/S224 phosphorylation promotes degradation through the ubiquitin-proteasome pathway, S245 phosphorylation counterbalances this by enhancing transcriptional activity during the window of ATF4 expression . This balance allows for precise temporal control of the stress response, ensuring robust but transient activation of ATF4-dependent genes.

What methods can be used to study the dynamics of ATF4 phosphorylation at S245 in live cells?

Investigating the dynamics of ATF4 phosphorylation at S245 in live cells requires sophisticated techniques that preserve temporal and spatial information. Several methodological approaches can be employed:

• Phospho-specific Fluorescent Reporters:

  • Engineer FRET-based biosensors with domains that specifically recognize phosphorylated S245

  • Design split fluorescent protein systems that reassemble upon S245 phosphorylation

  • These approaches allow real-time visualization of phosphorylation events with minimal cellular disruption

• Optogenetic Control Systems:

  • Develop light-controlled kinase systems to induce S245 phosphorylation with precise temporal control

  • Combine with live-cell imaging to monitor downstream effects

  • This approach enables cause-effect studies with unprecedented temporal resolution

• Advanced Microscopy Techniques:

  • Fluorescence Lifetime Imaging Microscopy (FLIM) to detect conformational changes upon phosphorylation

  • Super-resolution microscopy to track subcellular localization changes following S245 phosphorylation

  • Multi-photon microscopy for deeper tissue penetration in ex vivo or in vivo models

• Phospho-specific Proximity Labeling:

  • Adapt BioID or APEX2 systems with phospho-specific binding domains

  • These methods can identify proteins that specifically interact with phosphorylated ATF4-S245

• Multiplex Analysis Approaches:

  • Single-cell phospho-proteomics to correlate S245 phosphorylation with other signaling events

  • Live-cell RNA imaging to correlate phosphorylation status with target gene transcription

Each of these approaches offers distinct advantages and limitations. The ideal method depends on your specific research question, whether focused on kinetic parameters, spatial distribution, or downstream functional consequences of S245 phosphorylation. Combining multiple approaches can provide complementary insights into this dynamic post-translational modification and its role in stress response signaling.

How can you differentiate between the effects of phosphorylation at different sites (S219, S224, S245, S254) on ATF4 function?

Differentiating the specific contributions of multiple phosphorylation sites on ATF4 requires sophisticated experimental strategies that isolate individual modifications while maintaining physiological context:

• Site-Directed Mutagenesis Approaches:

  • Generate single phospho-site mutants (S→A to prevent phosphorylation; S→D/E to mimic constitutive phosphorylation)

  • Create combinatorial mutants to assess synergistic or antagonistic effects

  • Express these constructs in ATF4-null backgrounds to eliminate endogenous protein interference

  • Analyze effects on stability (half-life measurements), transcriptional activity (reporter assays), and protein-protein interactions

• Phosphorylation Site-Specific Antibodies:

  • Utilize antibodies that specifically recognize distinct phosphorylation sites (S219, S224, S245, S254)

  • Perform parallel Western blots to track site-specific phosphorylation kinetics under various conditions

  • Conduct immunoprecipitation with one phospho-specific antibody followed by blotting with another to identify multiply-phosphorylated species

• Mass Spectrometry-Based Approaches:

  • Employ targeted phospho-proteomics to quantitatively assess all phosphorylation sites simultaneously

  • Perform time-course analyses following various stressors to create site-specific phosphorylation profiles

  • Use parallel reaction monitoring (PRM) for sensitive quantification of low-abundance phosphopeptides

• Kinase-Substrate Mapping:

  • Identify specific kinases responsible for each phosphorylation site:

    • RSK2 for S245

    • PKA for S254

    • CK1 and CK2 for other sites

  • Use selective kinase inhibitors to block specific phosphorylation events

  • Employ analog-sensitive kinase mutants for temporal control of phosphorylation

• Functional Readout Systems:

  • Develop site-specific phosphorylation-dependent interaction screens

  • Create reporter systems for different ATF4 target genes to identify site-specific transcriptional effects

  • Analyze differential recruitment of co-factors to ATF4 depending on phosphorylation status

This multi-faceted approach can reveal how phosphorylation at S245 specifically contributes to ATF4 function, particularly in relation to other phosphorylation events. For example, while S219/S224 phosphorylation promotes degradation through the β-TrCP pathway, S245 phosphorylation enhances transcriptional activity . Understanding these distinct and sometimes opposing regulatory mechanisms is crucial for a comprehensive model of ATF4 regulation in stress response.

What are the methodological approaches to study crosstalk between phosphorylation and other post-translational modifications of ATF4?

Investigating the complex interplay between phosphorylation at S245 and other post-translational modifications (PTMs) of ATF4 requires sophisticated methodological approaches that can capture multi-dimensional regulatory networks:

• Sequential Immunoprecipitation Strategies:

  • First immunoprecipitation with Phospho-ATF4 (S245) antibody

  • Secondary immunoprecipitation with antibodies against acetylated lysine, ubiquitin, or hydroxylated proline

  • This sequential approach identifies ATF4 subpopulations with multiple modifications

• Integrated Mass Spectrometry:

  • Top-down proteomics to preserve intact ATF4 with all modifications

  • Middle-down approaches using limited proteolysis to maintain co-occurring modifications on larger peptides

  • Cross-linking mass spectrometry to identify modification-dependent structural changes

  • Analysis must account for the different ATF4 PTMs identified in studies:

• Proximity-Dependent Labeling for Modification-Specific Interactomes:

  • BioID or TurboID fusions with phosphorylation-deficient (S245A) versus phosphomimetic (S245D) ATF4

  • Compare interactomes to identify partners that recognize specific modification patterns

  • This reveals how S245 phosphorylation alters the recruitment of modifying enzymes for other PTMs

• Time-Resolved Multi-Modification Analysis:

  • Synchronize cells and apply stress stimuli

  • Collect samples at defined intervals and analyze multiple PTMs simultaneously

  • Construct temporal maps of modification patterns to reveal sequential or hierarchical relationships

• Molecular Dynamics and Structural Biology Approaches:

  • In silico modeling of how S245 phosphorylation affects protein conformation

  • Structural studies using NMR or cryo-EM of differentially modified ATF4

  • These approaches can predict how one modification might structurally influence the accessibility of other modification sites

These methodologies collectively provide insight into how phosphorylation at S245 by RSK2 is integrated with other modifications, such as the hydroxylation at P235 (which is located near the S245 site) , or the acetylation at K311 that inhibits ubiquitination . Understanding this PTM crosstalk is essential for deciphering the complete regulatory code that governs ATF4's function in the integrated stress response.

How can researchers investigate the role of S245 phosphorylation in ATF4-mediated gene expression during hypoxia?

Investigating the specific role of ATF4 S245 phosphorylation during hypoxia requires a multi-faceted experimental approach that integrates molecular, cellular, and in vivo techniques:

• Hypoxia-Specific Phosphorylation Dynamics:

  • Subject cells to controlled hypoxic conditions (1-0.1% O₂) using hypoxia chambers

  • Collect time-course samples to analyze S245 phosphorylation status using phospho-specific antibodies

  • Compare with other phosphorylation sites (S219, S224, S254) to establish site-specific hypoxic responses

  • Correlate with ATF4 protein levels and stability measurements

• Genetic Manipulation Strategies:

  • Generate cell lines expressing phospho-deficient (S245A) or phospho-mimetic (S245D) ATF4 mutants

  • Perform rescue experiments in ATF4-knockout backgrounds

  • Use CRISPR-Cas9 to create knock-in cell lines with endogenous S245A mutations

  • These approaches allow direct assessment of S245 phosphorylation requirement for hypoxic responses

• Genome-Wide Transcriptional Analysis:

  • Conduct RNA-seq comparing wild-type versus S245A-expressing cells under normoxia and hypoxia

  • Perform ATF4 ChIP-seq under the same conditions to map direct target genes

  • Integrate with phospho-ATF4 (S245) ChIP-seq to identify phosphorylation-dependent binding sites

  • This comprehensive approach identifies genes specifically regulated by S245 phosphorylation during hypoxia

• Signaling Pathway Integration:

  • Investigate the relationship between hypoxia-activated kinases and S245 phosphorylation

  • Explore potential connection between PERK-eIF2α activation (known to be critical for hypoxic induction of ATF4 ) and RSK2-mediated S245 phosphorylation

  • Use selective inhibitors to dissect pathway contributions

• In Vivo Models and Translational Research:

  • Analyze tumor xenografts with wild-type versus S245A ATF4 expression

  • Perform immunohistochemistry on tumor sections using phospho-ATF4 (S245) antibody

  • Correlate phosphorylation patterns with hypoxic regions (using pimonidazole or HIF-1α staining)

  • Compare findings with clinical samples from hypoxia-associated pathologies

This integrated approach can reveal the specific contribution of S245 phosphorylation to ATF4 function during hypoxia. Evidence suggests that eIF2α phosphorylation is required for hypoxic induction of ATF4 in vivo , but the specific role of S245 phosphorylation in this context remains to be fully elucidated. Understanding this regulatory mechanism could provide insights into therapeutic strategies for hypoxia-associated pathologies, including cancer and ischemic diseases.

What are the best approaches to validate antibody specificity for phospho-ATF4 (S245) in complex experimental systems?

Validating the specificity of phospho-ATF4 (S245) antibodies in complex experimental systems is critical for generating reliable data. A comprehensive validation strategy should include:

• Genetic Validation Approaches:

  • CRISPR/Cas9-engineered cell lines with ATF4 S245A mutation

  • ATF4 knockout cells as negative controls

  • Rescue experiments with wild-type versus S245A ATF4 expression

  • These genetic tools provide the gold standard for antibody specificity validation

• Biochemical Validation Methods:

  • Peptide competition assays using both phosphorylated and non-phosphorylated peptides

  • Lambda phosphatase treatment of samples to remove phosphorylation

  • Immunoprecipitation followed by mass spectrometry to confirm the identity of the detected protein

  • Immunodepletion experiments to confirm signal elimination

• Physiological Induction and Inhibition:

  • Manipulate known upstream regulators like RSK2, which phosphorylates ATF4 at S245

  • Use specific kinase inhibitors to block S245 phosphorylation

  • Create time-course experiments showing the dynamic regulation of the signal

  • These approaches validate the antibody in physiologically relevant contexts

• Cross-Validation with Multiple Antibodies:

  • Compare results from different phospho-ATF4 (S245) antibodies from various suppliers

  • Use different detection methods (WB, IHC, IF) to confirm consistency

  • Correlate with total ATF4 antibody signals in parallel experiments

  • This multi-antibody approach minimizes clone-specific artifacts

• Advanced Specificity Controls:

  • Proximity ligation assays (PLA) combining phospho-specific and total ATF4 antibodies

  • Phospho-proteomic analysis to correlate antibody signal with mass spectrometry data

  • Parallel analysis of known ATF4 target genes to correlate functional outcomes with detected phosphorylation

  • These methods provide orthogonal validation of antibody specificity

By implementing this comprehensive validation strategy, researchers can confidently use phospho-ATF4 (S245) antibodies even in complex experimental systems like tissue samples, primary cells, or disease models. Documentation of these validation steps also strengthens the credibility of published results and facilitates reproducibility in the field.

Future Directions in Phospho-ATF4 (S245) Research

The study of ATF4 phosphorylation at S245 continues to evolve, with several promising research directions emerging:

• Integration of multiple post-translational modifications on ATF4 into a comprehensive regulatory code that dictates its function in different cellular contexts and stress conditions.

• Development of more specific tools to manipulate S245 phosphorylation in vivo, such as optogenetic control systems or small-molecule modulators, enabling precise temporal and spatial regulation.

• Exploration of tissue-specific and disease-specific roles of ATF4 S245 phosphorylation, particularly in cancer, neurodegenerative disorders, and metabolic diseases where the integrated stress response plays a critical role.

• Investigation of the crosstalk between S245 phosphorylation and other signaling pathways, including hypoxia response, amino acid sensing, and endoplasmic reticulum stress.

• Translation of basic research findings into therapeutic approaches targeting ATF4 phosphorylation in diseases characterized by dysregulated stress responses.